Page 2 - Minimal Residual News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Minimal residual. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Minimal Residual Today - Breaking & Trending Today

Business News | BD Life Sciences - Biosciences Facilitates Knowledge-sharing Platform for Laboratory Personnel

Get latest articles and stories on Business at LatestLY. BD Life Sciences-Biosciences, a segment of BD (Becton, Dickinson, and Company) in collaboration with The Cytometry Society of India, Christian Medical College - Vellore organized a 2-day workshop for laboratory personnel on technological advancement and best practices made towards assessment of Minimal Residual Disease (MRD) in Acute Leukemia & Myeloma. This knowledge-sharing workshop was attended by nearly 100 participants, from across the country, Sri Lanka, Bangladesh, Nepal, Philippines, and Korea. Eminent speakers from leading medical colleges and hospitals elaborated on the technical and analytical components of MRD assessment. Business News | BD Life Sciences - Biosciences Facilitates Knowledge-sharing Platform for Laboratory Personnel. ....

Tamil Nadu , Sri Lanka , Arun Kumar Arunachalam , Christian Medical College , World Of Health , Cytometry Society Of India , Department Of Haematology , Bd Life Sciences , Cytometry Society , Minimal Residual Disease , Acute Leukemia , Atul Grover , Managing Director , South Asia , Minimal Residual , Associate Professor ,

Global MRD (Minimal Residual Disease) Testing Markets 2020-2025: Opportunities in Potential Long-Term Cost Savings & Technological Evolution of Testing


Share this article
Share this article
ResearchAndMarkets.com s offering.
The global market for MRD testing is predicted to grow at a CAGR of 15.64% over the forecast period, 2020-2025.
MRD Testing industry to be one of the most rapidly evolving and dynamic markets. The market is driven by certain factors, such as the rising incidence of hematologic malignancies, the increasing consumer awareness for tailored therapy, the increasing research funding from the National Cancer Institute, and the increasing disposable income in emerging economies.
The market is favored by the developments in the field of MRD testing solutions for hematologic malignancies and solid tumors. Currently, the MRD testing industry is witnessing an upsurge due to the rising incidence of hematologic malignancies, resulting in the high demand for sensitive testing solutions. Additionally, the high adoption of MRD tests among patients and the growing awareness among physicians regarding MRD ....

United States , Laura Wood , Natera Inc , Guardant Health , Quest Diagnostics Incorporated , National Cancer Institute , Adaptive Biotechnologies Corporation , Laboratory Developed Tests Ldts , Sysmex Corporation , Part Of Invitae Corporation , Considerations For Cellular Technology Platforms , Inivata Ltd , Opko Health Inc , Considerations For Molecular Technology Platforms , Invivoscribe Inc , Custom Research , Technology Consideration For Minimal Residual Disease , Office Hours Call , Laboratory Corporation Of America Holdings , Archerdx Inc , Research Methodology , Neogenomics Laboratories Inc , Research Funding , Mission Bio Inc , Company Profiles , Bio Rad Laboratories Inc ,

Global MRD (Minimal Residual Disease) Testing Market Report 2020-2025: One of the Most Rapidly Evolving and Dynamic Markets


Global MRD (Minimal Residual Disease) Testing Market Report 2020-2025: One of the Most Rapidly Evolving and Dynamic Markets
January 22, 2021 07:18 ET
| Source:
Research and Markets
Research and Markets
Dublin, IRELAND
ResearchAndMarkets.com s offering.
The global market for MRD testing is predicted to grow at a CAGR of 15.64% over the forecast period, 2020-2025.
MRD Testing industry to be one of the most rapidly evolving and dynamic markets. The market is driven by certain factors, such as the rising incidence of hematologic malignancies, the increasing consumer awareness for tailored therapy, the increasing research funding from the National Cancer Institute, and the increasing disposable income in emerging economies. ....

United States , Laura Wood , Natera Inc , Guardant Health , Quest Diagnostics Incorporated , National Cancer Institute , Adaptive Biotechnologies Corporation , Laboratory Developed Tests Ldts , Sysmex Corporation , Part Of Invitae Corporation , Considerations For Cellular Technology Platforms , Inivata Ltd , Opko Health Inc , Considerations For Molecular Technology Platforms , Invivoscribe Inc , Custom Research , Technology Consideration For Minimal Residual Disease , Office Hours Call , Laboratory Corporation Of America Holdings , Archerdx Inc , Research Methodology , Neogenomics Laboratories Inc , Research Funding , Mission Bio Inc , Company Profiles , Bio Rad Laboratories Inc ,